The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 02, 2014

Filed:

Oct. 12, 2012
Applicant:

National Jewish Health, Denver, CO (US);

Inventors:

Jerry A. Nick, Denver, CO (US);

Travis S. Walker, Denver, CO (US);

G. Scott Worthen, Denver, CO (US);

Assignee:

National Jewish Health, Denver, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/16 (2006.01); A01N 43/30 (2006.01); A01N 43/78 (2006.01); A01N 43/02 (2006.01); A61K 38/00 (2006.01); A01N 57/00 (2006.01); A61K 39/395 (2006.01); A61K 31/522 (2006.01); A61K 31/7072 (2006.01); A61K 31/7076 (2006.01); A61L 29/16 (2006.01); A61L 15/44 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/395 (2013.01); A61K 31/522 (2013.01); A61K 31/7072 (2013.01); A61K 31/7076 (2013.01); A61L 29/16 (2013.01); A61L 15/44 (2013.01); A61K 45/06 (2013.01); A61K 38/00 (2013.01); A61K 9/007 (2013.01); A61L 2300/432 (2013.01);
Abstract

Disclosed are compositions and methods for the inhibition of biofilm formation or reduction of existing or developing biofilms in a patient. These methods also inhibit the aggregation of bacteria that form biofilms in the airways. The methods include administering to a subject that has or is at risk of developing biofilms a compound or formulation that inhibits the formation or polymerization of actin microfilaments or depolymerizes actin microfilaments at or proximal to the site of biofilm formation. Such a compound can be administered in combination with a compound or formulation that inhibits the accumulation or activity of cells that are likely to undergo necrosis at or proximal to the site of biofilm formation (i.e., neutrophils). The methods and compositions can further include the use of anti-DNA and/or anti-mucin compounds, as well as other therapeutic compounds and compositions.


Find Patent Forward Citations

Loading…